Alloy and Pyxis spin out new 'company' around high-risk I/O, immunology targets
When CEO Lara Sullivan and the team at Pyxis sat down in 2019 to see which of the many targets from Thomas Gajewski’s immuno …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
